We investigated the in vitro and in vivo activities of caspofungin against Aspergillus terreus. The drug increased survival and reduced tissue fungal burden in neutropenic mice. Therefore, our data support the role of caspofungin in treating systemic infections due to this emerging pathogen.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1315968 | PMC |
| http://dx.doi.org/10.1128/AAC.49.12.5133-5135.2005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Influence of Fatty Acid Oxygenases PpoA and PpoC on Caspofungin Susceptibility.
J Fungi (Basel)
October 2024
School of Pharmaceutical Sciences of Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14040-903, Brazil.
can cause invasive pulmonary aspergillosis (IPA). Fungicidal azoles and fungistatic caspofungin (CAS) are the first- and second-line therapies, respectively, used to treat IPA. Treatment of with CAS or micafungin induces the production of the oxylipin 5,8-diHODE by the fungal oxygenase PpoA.
View Article and Find Full Text PDFImproved Broad Spectrum Antifungal Drug Synergies with Cryptomycin, a Cdc50-Inspired Antifungal Peptide.
ACS Infect Dis
November 2024
Public Health Research Institute and Department of Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey 07103, United States.
Fungal infections in humans are difficult to treat, with very limited drug options. Due to a confluence of factors, there is an urgent need for innovation in the antifungal drug space, particularly to combat increasing antifungal drug resistance. Our previous studies showed that Cdc50, a subunit of fungal lipid translocase (flippase), is essential for virulence and required for antifungal drug resistance, suggesting that fungal lipid flippase could be a novel drug target.
View Article and Find Full Text PDFAssessing the Efficacy of Chlorhexidine in Combating Most Important Causative Agents of Fungal Keratitis: An Comparative Study With Seven Antifungal Agents.
Curr Eye Res
October 2024
Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- The study focused on comparing the effectiveness of chlorhexidine (CHX) and seven antifungal agents against fungi from patients with fungal keratitis (FK).
- Testing involved 73 fungi samples using a standard method, where CHX demonstrated notable efficacy against various types of fungi at specific concentrations.
- Results suggested that CHX could be a cost-effective topical treatment for FK, especially in areas with limited access to antifungal medications, while posaconazole was identified as the most effective antifungal overall.
The top 10 papers on the treatment of invasive fungal infections, 2018-2023.
Ther Adv Infect Dis
October 2024
Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS, USA.
Article Synopsis
- Invasive fungal infections are common in hospitals and lead to significant health risks, affecting many patients with high rates of morbidity and mortality.
- The study aimed to identify the top 10 most influential articles from 2018 to 2023 regarding the treatment of these infections using a three-step consensus approach with expert panels.
- The final list of recommended publications focuses on treating conditions like invasive aspergillosis, candidiasis, and cryptococcosis, serving as a valuable resource for clinicians to enhance their antifungal treatment strategies.
Comparative Analysis of the Aspergillus fumigatus Cell Wall Modification and Ensuing Human Dendritic Cell Responses by β-(1,3)-Glucan Synthase Inhibitors-Caspofungin and Enfumafungin.
Mycopathologia
September 2024
Unité des Aspergillus, Institut Pasteur, 75015, Paris, France.
Caspofungin, a lipopeptide, is an antifungal drug that belong to the class of echinocandin. It inhibits fungal cell wall β-(1,3)-glucan synthase activity and is the second-line of drug for invasive aspergillosis, a fatal infection caused mainly by Aspergillus fumigatus. On the other hand, Enfumafungin is a natural triterpene glycoside also with a β-(1,3)-glucan synthase inhibitory activity and reported to have antifungal potential.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!